Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 5988-51-2
2. Dmae Tartrate
3. 2-(dimethylamino)ethanol (2r,3r)-2,3-dihydroxysuccinate
4. 29870-28-8
5. 2-dimethylaminoethanol Hydrogen L-(+)-tartrate
6. 2-dimethylaminoethanol Bitartrate
7. 2-(dimethylamino)ethanol L-(+)-bitartrate
8. D240j05w14
9. Ethanol, 2-(dimethylamino)-, (2r,3r)-2,3-dihydroxybutanedioate (1:1) (salt)
10. Dmae Bitartrate
11. Dimethylaminoethanol Tartrate
12. 2-(dimethylamino)ethanol Hydrogen L-(+)-tartrate
13. Unii-d240j05w14
14. N,n-dimethylethanolamine (+)-bitartrate Salt
15. Einecs 227-809-3
16. Deanol Tartrate
17. Dmae L-tartrate
18. N,n-dimethylethanolamine-tartrate Acid Salt
19. Ethanol, 2-(dimethylamino)-, Tartrate (1:1)
20. Oristar Dmae Tartrate
21. (2-hydroxyethyl)dimethylammonium Hydrogen Tartrate
22. Deanol Bitartrate [mi]
23. Dtxsid40952332
24. Deanol Bitartrate [who-dd]
25. Dimethylaminoethyl Bitartrate
26. Ethanol, 2-dimethylamino-, Tartrate
27. Mfcd00066567
28. 2-dimethylaminoethanol Tartrate
29. Akos027379845
30. Ethanol, 2-(dimethylamino)-, (2r,3r)-2,3-dihydroxybutanedioate (1:?)
31. Ethanol, 2-(dimethylamino)-, (2r,3r)-2,3-dihydroxybutanedioate (salt)
32. Cs-w012821
33. Ds-13096
34. Dimethylaminoethanol Tartrate [inci]
35. D1174
36. D89803
37. N,n-dimethylethanolamine-tartaric Acid Salt
38. Q27275997
39. 2-dimethylaminoethanol (+)-bitartrate Salt, >=99.0%
40. (2r,3r)-2,3-dihydroxybutanedioic Acid;2-(dimethylamino)ethanol
41. 6-bromo-5-methyl-2-methylsulfanyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-ol
42. Ethanol, 2-(dimethylamino)-, (2r, 3r)-2,3-dihydroxybutanedioate (salt)
43. Ethanol, 2-(dimethylamino)-, (2r,3r)-2,3-dihydroxybutanedioate (1:1)
44. Ethanol, 2-(dimethylamino)-, (r-(r*,r))-2,3-dihydroxybutanedioate (1:1) (salt)
45. Ethanol, 2-(dimethylamino)-, (r-(r*,r*))-2,3-dihydroxybutanedioate (1:1)
| Molecular Weight | 239.22 g/mol |
|---|---|
| Molecular Formula | C8H17NO7 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Exact Mass | 239.10050188 g/mol |
| Monoisotopic Mass | 239.10050188 g/mol |
| Topological Polar Surface Area | 139 Ų |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 163 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Market Place
ABOUT THIS PAGE
15
PharmaCompass offers a list of L (+) Dmae Bitartrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right L (+) Dmae Bitartrate manufacturer or L (+) Dmae Bitartrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred L (+) Dmae Bitartrate manufacturer or L (+) Dmae Bitartrate supplier.
PharmaCompass also assists you with knowing the L (+) Dmae Bitartrate API Price utilized in the formulation of products. L (+) Dmae Bitartrate API Price is not always fixed or binding as the L (+) Dmae Bitartrate Price is obtained through a variety of data sources. The L (+) Dmae Bitartrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A L (+) Dmae Bitartrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of L (+) Dmae Bitartrate, including repackagers and relabelers. The FDA regulates L (+) Dmae Bitartrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. L (+) Dmae Bitartrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of L (+) Dmae Bitartrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A L (+) Dmae Bitartrate supplier is an individual or a company that provides L (+) Dmae Bitartrate active pharmaceutical ingredient (API) or L (+) Dmae Bitartrate finished formulations upon request. The L (+) Dmae Bitartrate suppliers may include L (+) Dmae Bitartrate API manufacturers, exporters, distributors and traders.
click here to find a list of L (+) Dmae Bitartrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
L (+) Dmae Bitartrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of L (+) Dmae Bitartrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right L (+) Dmae Bitartrate GMP manufacturer or L (+) Dmae Bitartrate GMP API supplier for your needs.
A L (+) Dmae Bitartrate CoA (Certificate of Analysis) is a formal document that attests to L (+) Dmae Bitartrate's compliance with L (+) Dmae Bitartrate specifications and serves as a tool for batch-level quality control.
L (+) Dmae Bitartrate CoA mostly includes findings from lab analyses of a specific batch. For each L (+) Dmae Bitartrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
L (+) Dmae Bitartrate may be tested according to a variety of international standards, such as European Pharmacopoeia (L (+) Dmae Bitartrate EP), L (+) Dmae Bitartrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (L (+) Dmae Bitartrate USP).
